| [1] |
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension[J]. Eur Heart J, 2018, 39(33):3021-3104.
|
| [2] |
Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora[J]. Science, 2005, 308(5728): 1635-1638.
|
| [3] |
Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome[J]. Science, 2006, 312(5778):1355-1359.
|
| [4] |
Mushtaq N, Hussain S, Zhang S, et al. Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension[J]. Int J Mol Med, 2019, 44(2):513-522.
|
| [5] |
Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2012, 380(9859):2224-2260.
|
| [6] |
Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension[J]. Hypertension, 2015, 65(6):1331-1340.
|
| [7] |
Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora[J]. Kidney Int, 2013, 83(2):308-315.
|
| [8] |
Durgan DJ, Ganesh BP, Cope JL, et al. Role of the gut microbiome in obstructive sleep apnea-induced hypertension[J]. Hypertension, 2016, 67(2):469-474.
|
| [9] |
Katsimichas T, Antonopoulos AS, Katsimichas A, et al. The intestinal microbiota and cardiovascular disease[J]. Cardiovasc Res, 2019, 115(10):1471-1486.
|
| [10] |
Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis[J]. Proc Natl Acad Sci USA, 2011, 108 Suppl 1:4592-4598.
|
| [11] |
Ott SJ, El Mokhtari NE, Musfeldt M, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease[J]. Circulation, 2006, 113(7):929-937.
|
| [12] |
Jie Z, Xia H, Zhong SL, et al. The gut microbiome in atherosclerotic cardiovascular disease[J]. Nat Commun, 2017, 8(1):845.
|
| [13] |
Chan YK, Brar MS, Kirjavainen PV, et al. High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE(-/-) mice[J]. BMC Microbiol, 2016, 16(1):264.
|
| [14] |
Jin M, Qian Z, Yin J, et al. The role of intestinal microbiota in cardiovascular disease[J]. J Cell Mol Med, 2019, 23(4):2343-2350.
|
| [15] |
Rogler G, Rosano G. The heart and the gut[J]. Eur Heart J, 2014, 35(7):426-430.
|
| [16] |
Katsimichas T, Ohtani T, Motooka D, et al. Non-Ischemic heart failure with reduced ejection fraction is associated with altered intestinal microbiota[J]. Cir J, 2018, 82(6):1640-1650.
|
| [17] |
Cui X, Ye L, Li J, et al. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients[J]. Sci Rep, 2018, 8(1):635.
|
| [18] |
Kamo T, Akazawa H, Suda W, et al. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure[J]. PloS One, 2017, 12(3):e0174099.
|
| [19] |
Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J]. N Engl J Med, 2013, 368(17):1575-1584.
|
| [20] |
袁侨英，肖利，李学军，等.老年高血压患者并发症及特征分析[J].中华老年心脑血管病杂志，2013，15(3):239-240.
|
| [21] |
Durgan DJ, Lee J, McCullough LD, et al. Examining the role of the microbiota-gut-brain axis in stroke[J]. Stroke, 2019, 50 (8):2270-2277.
|
| [22] |
Yamashiro K, Tanaka R, Urabe T, et al. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke[J]. PLoS One, 2017, 12(2):e0171521.
|
| [23] |
Yin J, Liao SX, He Y, et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack[J]. J Am Heart Assoc, 2015, 4(11):e002699.
|
| [24] |
Stanley D, Mason LJ, Mackin KE, et al. Translocation and dissemination of commensal bacteria in post-stroke infection[J]. Nat Med, 2016, 22(11):1277-1284.
|
| [25] |
Singh V, Roth S, Llovera G, et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke[J]. J Neurosci, 2016, 36 (28):7428-7440.
|
| [26] |
Houlden A, Goldrick M, Brough D, et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production[J]. Brain Behav Immun, 2016, 57:10-20.
|
| [27] |
Benakis C, Brea D, Caballero S, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells[J]. Nat Med, 2016, 22(5):516-523.
|
| [28] |
Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of nutrients and other food components[J]. Eur J Nutrition, 2018, 57(1):1-24.
|
| [29] |
Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease[J]. Kidney Int, 2013, 83(6):1010-1016.
|
| [30] |
Xu KY, Xia GH, Lu JQ, et al. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients[J]. Sci Rep, 2017, 7(1):1445.
|
| [31] |
Wang F, Jiang H, Shi K, et al. Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients[J]. Nephrology, 2012, 17(8):733-738.
|
| [32] |
Pevsner-Fischer M, Blacher E, Tatirovsky E, et al. The gut microbiome and hypertension[J]. Curr Opinion Nephrol Hypertens, 2017, 26(1):1-8.
|
| [33] |
Hu J, Luo H, Wang J, et al. Enteric dysbiosis-linked gut barrier disruption triggers early renal injury induced by chronic high salt feeding in mice[J]. Exp Mol Med, 2017, 49(8):e370.
|
| [34] |
Marques FZ, Mackay CR, Kaye DM. Beyond gut feelings: how the gut microbiota regulates blood pressure[J]. Nat Rev Cardiol, 2018, 15(1):20-32.
|
| [35] |
Marques FZ, Nelson E, Chu PY, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice[J]. Circulation, 2017, 135(10):964-977.
|
| [36] |
Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a mediterranean diet[J]. N Engl J Med, 2013, 368(14):1279-1290.
|
| [37] |
Khalesi S, Sun J, Buys N, et al. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials[J]. Hypertension, 2014, 64(4):897-903.
|
| [38] |
Sun J, Wang F, Ling Z, et al. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota[J]. Brain Res, 2016, 1642:180-188.
|
| [39] |
Gallo A, Passaro G, Gasbarrini A, et al. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate[J]. World J Gastroenterol, 2016, 22(32):7186-7202.
|
| [40] |
Smits LP, Kootte RS, Levin E, et al. Effect of vegan fecal microbiota transplantation on carnitine and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome[J]. J Am Heart Assoc, 2018, 7(7):e008324.
|